Q3 2025 Holdings
Filed 2025-11-14 | 44 holdings | $540.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM | 457669307 | $70.8M | 491,805 | 13.1% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $52.9M | 862,613 | 9.8% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $52.6M | 2,466,684 | 9.7% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $42.3M | 5,367,798 | 7.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $40.8M | 754,007 | 7.6% |
| Biogen Inc(BIIB) | SPONSORED ADS | 09062X103 | $26.0M | 185,661 | 4.8% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $24.4M | 58,186 | 4.5% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $20.6M | 673,520 | 3.8% |
| Iovance Biotherapeutics Inc(IOVA) | COM NEW | 462260100 | $16.5M | 7,618,132 | 3.1% |
| Novocure LTD(NVCR) | COM | G6674U108 | $16.2M | 1,256,159 | 3.0% |
| Dyne Therapeutics Inc(DYN) | SPONSORED ADS | 26818M108 | $16.0M | 1,262,674 | 3.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $14.8M | 224,300 | 2.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $14.7M | 32,320 | 2.7% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $14.4M | 5,464,349 | 2.7% |
| Prothena Corp PLC(PRTA) | COM CL A | G72800108 | $12.9M | 1,324,028 | 2.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $11.1M | 369,531 | 2.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $10.7M | 265,497 | 2.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $10.1M | 654,930 | 1.9% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $6.7M | 1,544,619 | 1.2% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $5.9M | 408,006 | 1.1% |
| Align Technology Inc(ALGN) | COM | 016255101 | $5.7M | 45,735 | 1.1% |
| Alkermes PLC(ALKS) | COM | G01767105 | $5.5M | 183,938 | 1.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $4.8M | 109,831 | 0.9% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $4.7M | 64,700 | 0.9% |
| Caredx Inc(CDNA) | COM | 14167L103 | $4.6M | 316,204 | 0.9% |
| Taysha Gene Therapies Inc(TSHA) | COM | 877619106 | $4.1M | 1,246,033 | 0.8% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $3.8M | 1,020,547 | 0.7% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.0M | 1,566,840 | 0.6% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $2.7M | 41,226 | 0.5% |
| Travere Therapeutics Inc(TVTX) | COM SHS | 89422G107 | $2.6M | 110,719 | 0.5% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $2.6M | 33,640 | 0.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.5M | 18,117 | 0.5% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.5M | 105,427 | 0.5% |
| Pyxis Oncology Inc(PYXS) | COM | 747324101 | $2.3M | 1,037,421 | 0.4% |
| Biontech SE(BNTX) | COM | 09075V102 | $1.9M | 19,614 | 0.4% |
| Bicycle Therapeutics PLC(BCYC) | COM | 088786108 | $1.7M | 221,071 | 0.3% |
| Aldeyra Therapeutics Inc(ALDX) | SPONSORED ADR | 01438T106 | $1.2M | 225,465 | 0.2% |
| Humana Inc(HUM) | COM | 444859102 | $1.0M | 3,985 | 0.2% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $791.3K | 59,985 | 0.1% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $574.8K | 108,865 | 0.1% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $488.8K | 24,500 | 0.1% |
| Proqr Therapeutics NV | SHS EURO | N71542109 | $402.2K | 188,807 | 0.1% |
| Akari Therapeutics PLC(AKTX) | COM | 00972G207 | $147.5K | 146,024 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $92.1K | 15,047 | 0.0% |